Comparison of Oxoferrin (Tetrachlorodecoxide) Drops Dressing versus Normal Saline Dressings in Management of Diabetic Foot Ulcers
DOI:
https://doi.org/10.51253/pafmj.v75iSUPPL-7.11701Keywords:
Diabetic Foot, Granulation Tissue, Oxoferrin, Wagner GradeAbstract
Objective: To compare the wound outcome of “Oxoferrin (Tetrachlorodecoxide) drops dressing” versus “normal saline dressings” in management of diabetic foot ulcers.
Study Design: Quasi-experimental study.
Place and Duration of Study: Pakistan Air Force Hospital Mushaf, Sargodha Pakistan, from May 2023 to Feb 2024.
Methodology: We included 210 patients with diabetic foot ulcers. 10 patients were excluded making final sample of 200 which were divided into “Oxoferrin (Tetrachlorodecoxide) drops dressing” & “normal saline dressings” Groups. Patients were treated for four weeks and were then assessed for outcomes.
Results: No difference was observed between Groups for baseline size of wound (p=0.809). “Size of wound” after four weeks of therapy in “Oxoferrin (Tetrachlorodecoxide) drops dressing” Group (A) was 131.70±11.83 cm2 while in “normal saline dressings” Group (B) it was 151.74±13.22 cm2, (p<0.001). Mean reduction in size of wound and % reduction in size of wound was significantly greater in “Oxoferrin (Tetrachlorodecoxide) drops dressing” Group, (p<0.001). Median patient satisfaction VAS in “Oxoferrin (Tetrachlorodecoxide) drops dressing” Group (A) was 9(7-9) while in “normal saline dressings” Group (B) it was 6(3-9), (p<0.001).
Conclusion: “Oxoferrin (Tetrachlorodecoxide) drops dressing” provides better wound outcomes and patient satisfaction in management of “diabetic foot ulcers”.
Downloads
References
1. Dias Â, Ferreira G, Vilaça M, Pereira MG. Quality of life in patients with diabetic foot ulcers: a cross-sectional study. Adv Skin Wound Care 2022; 35(12): 661-668.
https://doi.org/10.1097/01.ASW.0000891864.37619.34
2. Rossboth S, Lechleitner M, Oberaigner W. Risk factors for diabetic foot complications in type 2 diabetes-A systematic review. Endocrinol Diabetes Metab 2020; 4(1): e00175.
https://doi.org/10.1002/edm2.175
3. Akkus G, Sert M. Diabetic foot ulcers: A devastating complication of diabetes mellitus continues non-stop in spite of new medical treatment modalities. World J Diabetes 2022; 13(12): 1106-1121.
https://doi.org/10.4239/wjd.v13.i12.1106
4. Armstrong DG, Boulton AJM, Bus SA. Diabetic foot ulcers and their recurrence. N Engl J Med 2017; 376(24): 2367-2375.
https://doi.org/10.1056/NEJMra1615439
5. Akhtar S, Ali A, Ahmad S, Khan MI, Shah S, Hassan F. The prevalence of foot ulcers in diabetic patients in Pakistan: A systematic review and meta-analysis. Front Public Health 2022; 10: 1017201.
https://doi.org/10.3389/fpubh.2022.1017201
6. Saleem S, Hayat N, Ahmed I, Ahmed T, Rehan AG. Risk factors associated with poor outcome in diabetic foot ulcer patients. Turk J Med Sci 2017; 47(3): 826-831.
https://doi.org/10.3906/sag-1602-119
7. Lobmann R, Grünerbel A, Lawall H, Lüdemann C, Morbach S, Tigges W, et al. Impact of wound duration on diabetic foot ulcer healing: evaluation of a new sucrose octasulfate wound dressing. J Wound Care 2020; 29(10): 543-551.
https://doi.org/10.12968/jowc.2020.29.10.543
8. Tan WS, Arulselvan P, Ng SF, Mat Taib CN, Sarian MN, Fakurazi S. Improvement of diabetic wound healing by topical application of Vicenin-2 hydrocolloid film on Sprague Dawley rats. BMC Complement Altern Med 2019; 19(1): 20.
https://doi.org/10.1186/s12906-018-2427-y
9. Parikh R, Bakhshi G, Naik M, Gaikwad B, Jadhav K, Tayade M. The efficacy and safety of tetrachlorodecaoxide in comparison with super-oxidised solution in wound healing. Arch Plast Surg 2016; 43(5): 395-401.
https://doi.org/10.5999/aps.2016.43.5.395
10. Hinz J, Hautzinger H, Stahl KW. Rationale for and results from a randomised, double-blind trial of tetrachlorodecaoxygen anion complex in wound healing. Lancet 1986; 1(8485): 825-828.
https://doi.org/10.1016/S0140-6736(86)90939-6
11. ElSayed NA, Aleppo G, Aroda VR, Bannuru RR, Brown FM, Bruemmer D, et al., on behalf of the American Diabetes Association. 2. Classification and Diagnosis of Diabetes: Standards of Care in Diabetes-2023. Diabetes Care 2023; 46(Suppl 1): S19-S40. https://doi.org/10.2337/dc23-S002
12. Obirikorang Y, Obirikorang C, Anto EO, Acheampong E, Batu EN, Stella AD, et al. Knowledge of complications of diabetes mellitus among patients visiting the diabetes clinic at Sampa Government Hospital, Ghana: a descriptive study. BMC Public Health 2016; 16: 637.
https://doi.org/10.1186/s12889-016-3311-7
13. Spampinato SF, Caruso GI, De Pasquale R, Sortino MA, Merlo S. The treatment of impaired wound healing in diabetes: looking among old drugs. Pharmaceuticals 2020; 13(4): 60.
https://doi.org/10.3390/ph13040060
14. Wu L, Norman G, Dumville JC, O'Meara S, Bell-Syer SE. Dressings for treating foot ulcers in people with diabetes: an overview of systematic reviews. Cochrane Database Syst Rev 2015; 2015(7): CD010471.
https://doi.org/10.1002/14651858.CD010471.pub2
15. Vas P, Rayman G, Dhatariya K, Driver V, Hartemann A, Londahl M, et al. Effectiveness of interventions to enhance healing of chronic foot ulcers in diabetes: a systematic review. Diabetes Metab Res Rev 2020; 36(Suppl_1): e3284.
https://doi.org/10.1002/dmrr.3284
16. Meamar R, Ghasemi-Mobarakeh L, Norouzi MR, Siavash M, Hamblin MR, Fesharaki M. Improved wound healing of diabetic foot ulcers using human placenta-derived mesenchymal stem cells in gelatin electrospun nanofibrous scaffolds plus a platelet-rich plasma gel: A randomized clinical trial. Int Immunopharmacol 2021; 101(Pt_B): 108282.
https://doi.org/10.1016/j.intimp.2021.108282
17. Adeniyi AF, Sanya AO, Fasanmade AA, Borodo M, Uloko AE. Relationship between duration of diagnosis and neuromusculoskeletal complications of middle-aged type 2 diabetes patients. West Afr J Med 2010; 29(6): 393-397.
https://doi.org/10.4314/wajm.v29i6.68274
18. Chang YC, Huang YY, Hung SY, Yeh JT, Lin CW, Chen IW, et al. Are current wound classifications valid for predicting prognosis in people treated for limb-threatening diabetic foot ulcers? Int Wound J 2023; 14338.
https://doi.org/10.1111/iwj.14338
19. Shah P, Inturi R, Anne D, Jadhav D, Viswambharan V, Khadilkar R, et al. Wagner's classification as a tool for treating diabetic foot ulcers: our observations at a suburban teaching hospital. Cureus 2022; 14(1): e21501.
https://doi.org/10.7759/cureus.21501
20. Shah P, Inturi R, Anne D, Jadhav D, Viswambharan V, Khadilkar R, et al. Wagner's classification as a tool for treating diabetic foot ulcers: our observations at a suburban teaching hospital. Cureus. 2022; 14(1): e21501.
https://doi.org/10.7759/cureus.21501
21. Ramarao K, Ramu L Comparative study between the effect of topical insulin and normal saline dressing in healing of diabetic foot ulcers. Int J Contemp Med Res 2017; 4(6): 1337-1339.
22. Rashid A, Lateef A, Gulzar M, Muhammad D, Rehman N. Comparison between role of honey dressing and oxoferin (tetrachlorodecaoxide) dressing in the management of infected wounds in diabetic amputated limbs. Ann Punjab Med Coll 2014; 8(1): 73-77.
Downloads
Published
Issue
Section
License
Copyright (c) 2025 Muhammad Zargham Nasir Khan, Shehzad Ahmed Abbasi, Nauman Tasneem, Muhammad Nafe Bin Tahir, Syeda Rida Mashhadi, Sidra Abdullah
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
How to Cite
